AI assistant
CONTROL BIONICS LIMITED — Regulatory Filings 2021
Nov 17, 2021
64611_rns_2021-11-17_b31a9dc9-5d87-4618-8832-434b7407242f.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [146 x 46] intentionally omitted <==
18 November 2021
ASX ANNOUNCEMENT
Change of Address
Control Bionics Limited (ASX:CBL) advises that, effective 19 November 2021, the registered office and principal place of business has changed to:
Level 5, Suite 5.01, 697 Burke Road CAMBERWELL, VIC 3124
All other contact details remain unchanged.
This announcement was authorised by the CEO, Rob Wong.
Investors
Brett Crowley - Company Secretary [email protected]
Business/Client Inquiries
Rob Wong - CEO [email protected]
For further information visit the website: https://www.controlbionics.com/
About Control Bionics:
Control Bionics is an assistive technology device company that enables people with communication challenges to participate more fully in daily life. It’s augmentative and alternative communication (AAC) offerings help people with a range of conditions to find their ‘voice.’ Control Bionics’ Trilogy product line is the only AAC product to harness three modalities—touch, eye, and NeuroNode control — giving users the ultimate, personalized opportunity to express themselves.
Control Bionics Limited Registered Office: Level 5, Suite 5.01, 697 Burke Road, CAMBERWELL, VIC 3124 T: +61 3 9897 3576 W: www.controlbionics.com
ABN: 45 115 465 462